MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/13543776.2026.2725660

Медицинская библиотека · Expert opinion on therapeutic patents · 2026

Overcoming the blood-brain barrier for therapeutics targeting neurodegenerative diseases: a patent review (2020-present).

Huang Daowei, Lu Roujun, Tang Ruijing, Sun Jiarui, Sang Zhipei

СтатьяОбзорПеревод пока не подготовлен

Аннотация

INTRODUCTION

The blood-brain barrier (BBB) restricts drug entry into the CNS, with most therapeutics showing <1% brain penetration, limiting efficacy in neurodegenerative diseases.

AREAS COVERED: Patents (2020-2026) were retrieved from SciFinder, Web of Science, PubMed, and Reaxys using combinations of 'blood-brain barrier,' 'brain delivery,' and neurodegenerative disease terms. Technologies were included if supported by in vitro or in vivo BBB‑penetration evidence for neurodegenerative indications; purely computational, non‑English untranslated, and non‑targeted conventional formulation patents were excluded. Eligible patents were classified into protein/antibody‑based, small molecule, nanocarrier, physical‑assisted, permeability enhancer, and emerging technology categories.

EXPERT OPINION: Receptor-mediated transcytosis, dual-targeting ligands, and ultrasound opening are enhancing delivery precision; emerging systems (small molecules, peptides, nanozymes) combine penetration with target inhibition, overcoming traditional bottlenecks and accelerating clinical translation.

Для цитирования: Huang Daowei, Lu Roujun, Tang Ruijing, Sun Jiarui, Sang Zhipei. Overcoming the blood-brain barrier for therapeutics targeting neurodegenerative diseases: a patent review (2020-present).. Expert opinion on therapeutic patents. 2026. DOI: 10.1080/13543776.2026.2725660.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.